Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.38B |
| 2 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$685M |
| 3 |
Home Depot
HD
|
+$497M |
| 4 |
Bausch Health
BHC
|
+$314M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$418M |
| 2 |
AT&T
T
|
+$243M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$193M |
| 4 |
Southern Company
SO
|
+$163M |
| 5 |
DELL
DELL INC
DELL
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.21% |
| 2 | Financials | 5.16% |
| 3 | Technology | 4.66% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Energy | 3.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DFT
1301
DELISTED
DuPont Fabros Technology Inc.
DFT
| $9.31M | 0.01% |
388,000
+174,802
| +82% | +$4.25M |
|
1302
PUT
Simon Property Group
SPG
$74.4B
| $9.3M | 0.01% |
65,056
-28,701
| -31% | -$4.13M |
|
|
NBIS
1303
CALL
Nebius Group N.V.
NBIS
$48.3B
| $9.3M | 0.01% |
+216,300
| New | +$8.41M |
|
1304
Jabil
JBL
$33B
| $9.3M | 0.01% |
547,044
+273,897
| +100% | +$5.56M |
|
1305
CALL
Cigna
CI
$73.7B
| $9.28M | 0.01% |
106,700
+77,800
| +269% | +$6.36M |
|
|
SCHW
1306
PUT
Charles Schwab
SCHW
$183B
| $9.27M | 0.01% |
356,600
-23,600
| -6% | -$563K |
|
1307
CALL
Cardinal Health
CAH
$53.9B
| $9.25M | 0.01% |
140,200
+73,700
| +111% | +$4.5M |
|
1308
Fossil Group
FOSL
$293M
| $9.24M | 0.01% |
77,651
-13,179
| -15% | -$1.63M |
|
1309
PUT
Herc Holdings
HRI
$5.02B
| $9.17M | 0.01% |
109,133
+30,900
| +39% | +$2.21M |
|
1310
CALL
General Mills
GIS
$19.1B
| $9.15M | 0.01% |
186,700
-1,300
| -0.7% | -$64.7K |
|
1311
Republic Services
RSG
$64.8B
| $9.13M | 0.01% |
276,568
+46,340
| +20% | +$1.57M |
|
1312
BP
BP
$116B
| $9.11M | 0.01% |
232,035
-280,644
| -55% | -$10.4M |
|
1313
Domino's
DPZ
$11.5B
| $9.11M | 0.01% |
131,995
+87,495
| +197% | +$5.99M |
|
1314
CALL
Elevance Health
ELV
$81.5B
| $9.1M | 0.01% |
98,900
-39,300
| -28% | -$3.49M |
|
|
SVU
1315
DELISTED
SUPERVALU Inc.
SVU
| $9.1M | 0.01% |
185,715
+41,423
| +29% | +$2.04M |
|
|
CERN
1316
CALL
DELISTED
Cerner Corp
CERN
| $9.1M | 0.01% |
165,400
-129,000
| -44% | -$7.23M |
|
|
1317
PUT
BP
BP
$116B
| $9.09M | 0.01% |
231,550
-73,476
| -24% | -$2.74M |
|
|
SINA
1318
PUT
DELISTED
Sina Corp
SINA
| $9.08M | 0.01% |
108,100
-11,400
| -10% | -$932K |
|
1319
PIMCO Dynamic Income Fund
PDI
$7.39B
| $9.08M | 0.01% |
313,106
+70,360
| +29% | +$2.06M |
|
|
SGY
1320
DELISTED
Stone Energy
SGY
| $9.06M | 0.01% |
4,692
-721
| -13% | -$1.38M |
|
|
DTV
1321
CALL
DELISTED
DIRECTV COM STK (DE)
DTV
| $9.06M | 0.01% |
131,300
-600
| -0.5% | -$38.4K |
|
1322
Wipro
WIT
$19.6B
| $9.04M | 0.01% |
4,017,957
+3,922,810
| +4,123% | +$8.44M |
|
1323
Hormel Foods
HRL
$13.8B
| $9.03M | 0.01% |
401,504
+57,850
| +17% | +$1.27M |
|
1324
PUT
Toyota
TM
$224B
| $9M | 0.01% |
74,400
-4,700
| -6% | -$591K |
|
1325
DaVita
DVA
$15.4B
| $8.97M | 0.01% |
142,343
+14,763
| +12% | +$866K |
|
Similar funds
Barclays's Q4 2013 Portfolio in Review
As of Q4 2013, Barclays held 8,027 positions worth $97.6B, up 16% from $83.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $6.88B of net new capital in Q4 2013, opening 582 new positions and adding to 3,285 existing holdings. Its largest new stake was LyondellBasell Industries: 1,615,904 shares worth $129M.
By sector, the portfolio is most concentrated in Healthcare at 5.2% of assets, up from 4.2% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $418M trimmed.
- Barclays's largest Q4 2013 buy was LyondellBasell Industries: 1,615,904 shares worth $129M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2013, an estimated $3.38B increase.
- Barclays's biggest Q4 2013 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $418M.
- Barclays fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $193M.
- Barclays's ten largest holdings make up 25% of its $97.6B portfolio in Q4 2013.
- Barclays opened 582 new positions and closed 442 in Q4 2013.
- Barclays's portfolio value rose 16% quarter-over-quarter to $97.6B.
Based on Barclays's 13F filing for Q4 2013, filed 13 Feb 2014.